Fig. 5.
Fig. 5. p53 stabilization is increased by lactacystin treatment of PHA–PBMC and MT-2 cells. / Normal PHA–PBMC and MT-2 cells were treated with lactacystin, and the cell lysates were immunoprecipitated with the N-20 antibody. The blots were immunoblotted first with the N-20 antibody (A) and, after stripping, with the FL-393 antibody (B). + and − refer to the presence or absence of the drugs, respectively.

p53 stabilization is increased by lactacystin treatment of PHA–PBMC and MT-2 cells.

Normal PHA–PBMC and MT-2 cells were treated with lactacystin, and the cell lysates were immunoprecipitated with the N-20 antibody. The blots were immunoblotted first with the N-20 antibody (A) and, after stripping, with the FL-393 antibody (B). + and − refer to the presence or absence of the drugs, respectively.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal